期刊文献+

Molecular Docking and 3D-QSAR Research of Biphenyl Carboxylic Acid MMP-3 Inhibitors 被引量:6

Molecular Docking and 3D-QSAR Research of Biphenyl Carboxylic Acid MMP-3 Inhibitors
下载PDF
导出
摘要 The molecular docking by LigandFit docking of Discovery Studios 2.5 was employed to the three-dimensional quantitative structure-activity relationship(3D-QSAR) studies of biphenyl carboxylic acid MMP3 inhibitors.A significant correlation coefficient was obtained between dock scores and biological activities.Based on the optimal docking conformations,3D-HoVAIF was employed to the QSAR studies of 51 biphenyl carboxylic acid MMP-3 inhibitors.R2 and Q_CV2(leave-one-out,LOO) of the optimal 3D-HoVAIF-PLS model were 0.873 and 0.841 respectively.The conclusions obtained from the PLS analysis were in agreement with the docking results. The molecular docking by LigandFit docking of Discovery Studios 2.5 was employed to the three-dimensional quantitative structure-activity relationship(3D-QSAR) studies of biphenyl carboxylic acid MMP3 inhibitors.A significant correlation coefficient was obtained between dock scores and biological activities.Based on the optimal docking conformations,3D-HoVAIF was employed to the QSAR studies of 51 biphenyl carboxylic acid MMP-3 inhibitors.R2 and Q_CV2(leave-one-out,LOO) of the optimal 3D-HoVAIF-PLS model were 0.873 and 0.841 respectively.The conclusions obtained from the PLS analysis were in agreement with the docking results.
出处 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2012年第3期443-451,共9页 结构化学(英文)
基金 Sponsored by the National Natural Science Foundation of China (No. 31170747) Natural Science Foundation of Chongqing Municipality (CQ CSTC, No. 2010BB5304) Science and Technology project of Chongqing Education Commission (KJ110804) Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (No. 2009BST03)
关键词 QSAR 3D-HoVAIF molecular docking MMP3 inhibitors QSAR 3D-HoVAIF molecular docking MMP3 inhibitors
  • 相关文献

参考文献20

  • 1Sternlicht, M.; Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 2001, 17, 463-516.
  • 2Verma, R,. P.; Hansch, C. Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q) SARs. Bio. Med. Chem. 2007, 15, 2223-2268.
  • 3Fingleton, B. Matrix metalloproteinases as valid clinical targets. Curt. Pharm. Des. 2007, 13, 333-346.
  • 4Distler, J. H.; Jingel, A.; Hubcr, L. C. The induction of matrix mcllop roteinsc and cytokinc expression in synovi~ fibroblasts stimulated with. immune cell microparticles. Proc. Natl. Acad. Sci. USA 2005, I02, 2892-2897.
  • 5Sun, H. B.; Yokota, H. Reduction of cytokine-induced expression and aclivity of MMP-I and MMP-13 by mechanical swain in MH7A rheumatoid synovial cells. Matrix. Bid. 2002, 21, 63--270.
  • 6Momberger, T. S.; L~vick, J. R.; Mason, R. M. Hyaluronan secretion by synovicytes is mechanos~nsitive. Matrix. Biol. 2005, 24, 510-519.
  • 7Tang, Z. Y.; Yang, L; Wang, Y Q. Contributions of different intraarticular tissues to the acute phase elevation of synovial fluid MMP-2 following ratACL rupture. J. Orthop. Res. 2009, 27, 243-248.
  • 8Greene, J.; Wang, M.; Liu, Y. E.; Raymond, L. A.; Rosen, C.; Shi,YL E. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase. Biol. Chem. 1996, 271, 30375-30380.
  • 9Skiles, J. W. The design, structures and clinical update of small molecular weight matrix metalloproteinase inhibitors. Curt. Med. Chem. 2004, 11, 2911-2977.
  • 10Tuccinardi, T.; Nuti, E.: Ortore, G.; Rossello, A.; Avramova, S. I.; Martinelli, A. Development of a receptor-based 3D-QSAR study for the analysis of MMP2, MMP3, and MMP9 inhibitors. Bioorg. Med. Chem. 2008, 16, 7749-7758.

同被引文献43

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部